comparemela.com

Latest Breaking News On - News ratings for terns pharmaceuticals daily - Page 1 : comparemela.com

Decheng Capital LLC Takes $4.64 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)

Decheng Capital LLC Takes $4.64 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Exchange-commission
Securities-exchange-commission
Quarter-for-terns-pharmaceuticals
Vivo-opportunity-llc
Nasdaq
Russell-investments-group-ltd
News-ratings-for-terns-pharmaceuticals-daily
Terns-pharmaceuticals-trading-down
Decheng-capital
Franklin-resources-inc
Terns-pharmaceuticals-inc

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $14.94 Consensus PT from Brokerages

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month price objective […]

Affinity-asset-advisors
Terns-pharmaceuticals
Terns-pharmaceuticals-price-performance
Analyst-recommendations-for-terns-pharmaceuticals
Terns-pharmaceuticals-company-profile
Vivo-opportunity-llc
News-ratings-for-terns-pharmaceuticals-daily
Nasdaq
Insider-activity-at-terns-pharmaceuticals
Terns-pharmaceuticals-inc
Get-free-report

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) have earned an average rating of “Moderate Buy” from the eight research firms that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month […]

Nasdaq
Vivo-opportunity-llc
Terns-pharmaceuticals-inc
Affinity-asset-advisors
Terns-pharmaceuticals-stock-performance
News-ratings-for-terns-pharmaceuticals-daily
Analyst-recommendations-for-terns-pharmaceuticals
Terns-pharmaceuticals
Insider-transactions-at-terns-pharmaceuticals
Get-free-report
Vivo-opportunity

Terns Pharmaceuticals (NASDAQ:TERN) Earns "Neutral" Rating from HC Wainwright

HC Wainwright reaffirmed their neutral rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. The brokerage currently has a $5.50 target price on the stock. HC Wainwright also issued estimates for Terns Pharmaceuticals’ Q2 2024 earnings at ($0.33) EPS, FY2024 earnings at […]

Affinity-asset-advisors
Insider-transactions-at-terns-pharmaceuticals
Terns-pharmaceuticals-stock-performance
Analyst-recommendations-for-terns-pharmaceuticals
Janus-henderson-group
Vivo-opportunity-llc
Terns-pharmaceuticals
News-ratings-for-terns-pharmaceuticals-daily
Walleye-trading
Pricet-rowe-associates-inc
Institutional-investors-weigh-in-on-terns-pharmaceuticals

Terns Pharmaceuticals' (TERN) Neutral Rating Reaffirmed at HC Wainwright

HC Wainwright restated their neutral rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a research report report published on Tuesday morning, Benzinga reports. They currently have a $5.50 target price on the stock. HC Wainwright also issued estimates for Terns Pharmaceuticals’ Q2 2024 earnings at ($0.33) EPS, FY2024 earnings at ($1.36) EPS, […]

China
Bleakley-financial-group
Securities-exchange-commission
Vivo-opportunity-llc
Institutional-trading-of-terns-pharmaceuticals
Simplicity-solutions
China-universal-asset-management-co
Terns-pharmaceuticals
Terns-pharmaceuticals-stock-performance
Analyst-recommendations-for-terns-pharmaceuticals
Insider-transactions-at-terns-pharmaceuticals

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.